Traditional biomarker discovery methods often rely on predefined libraries, limiting the scope of identified molecules and potentially missing critical, novel biomarkers. Analyzing complex biological samples requires comprehensive techniques that can capture a broad view of the metabolome and proteome without bias.

Panome Bio offers untargeted mass spectrometry-based metabolomics, proteomics, and multi-omics services for comprehensive biomarker discovery. Their approach profiles the entire metabolome and proteome without being limited by predefined libraries, enabling the identification of novel and biologically relevant molecules. By integrating metabolomics, proteomics, and transcriptomics data through a proprietary bioinformatics pipeline, Panome Bio provides researchers with superior mechanistic insights and actionable results. The company's integrated workflow handles all complexities of sample preparation, data acquisition, and analysis, delivering high-quality data reports and raw data in as little as four weeks.

Untargeted metabolomics using mass spectrometry to identify a wide range of metabolites without relying on predefined libraries.

Discovery proteomics to uncover thousands of proteins, including low-abundance proteins and proteoforms.

Integrated multi-omics analysis combining metabolomics, proteomics, and transcriptomics data for enhanced mechanistic insights.

Proprietary bioinformatics pipeline and database for data processing, curation, and statistical analysis.

Metabolic flux and targeted metabolomics services for deeper insights into metabolic pathways.

Services include sample preparation, data acquisition, and data analysis.

LC/MS techniques and computational pipelines to profile the entire metabolome and proteome.

Panome Bio serves researchers in pharmaceutical, biotechnology, and academic institutions seeking to discover novel biomarkers and gain mechanistic insights from complex biological samples.